Comment on " Pneumocystis jirovecii Pneumonia in Patients Treated for Solid Organ Malignancy"
Comment on " Pneumocystis jirovecii Pneumonia in Patients Treated for Solid Organ Malignancy"
About this item
Full title
Author / Creator
Publisher
United States: Ochsner Clinic Foundation Academic Center - Publishing Services
Journal title
Language
English
Formats
Publication information
Publisher
United States: Ochsner Clinic Foundation Academic Center - Publishing Services
Subjects
More information
Scope and Contents
Contents
Current recommendations suggest prophylaxis for groups with a risk >3.5%, but the 0.6% incidence rate reported by Waks et al suggests that the >3.5% threshold may not be appropriate. 3 In our view, the existing evidencecalls for us to take a hard look at the current guidelines and become much more proactive about PJP prevention in patients on dose-...
Alternative Titles
Full title
Comment on " Pneumocystis jirovecii Pneumonia in Patients Treated for Solid Organ Malignancy"
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3165947370
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3165947370
Other Identifiers
ISSN
1524-5012
E-ISSN
1524-5012
DOI
10.31486/toj.24.0088
